These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26206583)

  • 21. P-cresol induces disruption of cardiomyocyte adherens junctions.
    Peng YS; Lin YT; Wang SD; Hung KY; Chen Y; Wang SM
    Toxicology; 2013 Apr; 306():176-84. PubMed ID: 23466501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy.
    Liao XH; Wang N; Liu QX; Qin T; Cao B; Cao DS; Zhang TC
    IUBMB Life; 2011 Jan; 63(1):54-61. PubMed ID: 21280178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
    Duan Y; Zhou B; Su H; Liu Y; Du C
    Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase.
    Tan WQ; Wang K; Lv DY; Li PF
    J Biol Chem; 2008 Oct; 283(44):29730-9. PubMed ID: 18772130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
    Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
    Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
    Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
    J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of PKCalpha in insulin-induced PKCdelta expression: Importance of SP-1 and NFkappaB transcription factors.
    Horovitz-Fried M; Sampson SR
    Biochem Biophys Res Commun; 2007 Jan; 352(1):78-83. PubMed ID: 17109817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardin regulates BMP10 expression and is required for heart development.
    Huang J; Elicker J; Bowens N; Liu X; Cheng L; Cappola TP; Zhu X; Parmacek MS
    J Clin Invest; 2012 Oct; 122(10):3678-91. PubMed ID: 22996691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin.
    Yoshida T; Hoofnagle MH; Owens GK
    Circ Res; 2004 Apr; 94(8):1075-82. PubMed ID: 15016729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
    Wang K; Long B; Zhou J; Li PF
    J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
    Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
    Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
    Xu Y; Liang C; Luo Y; Xing W; Zhang T
    J Cell Biochem; 2019 Jun; 120(6):9047-9055. PubMed ID: 30582211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-466h-5p induces expression of myocardin with complementary promoter sequences.
    Luo Y; Liang C; Xu Y; Zhang T
    Biochem Biophys Res Commun; 2019 Jun; 514(1):187-193. PubMed ID: 31029421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in Na(+) current by angiotensin II is mediated by PKCα in mouse and human-induced pluripotent stem cell-derived cardiomyocytes.
    Mathieu S; El Khoury N; Rivard K; Gélinas R; Goyette P; Paradis P; Nemer M; Fiset C
    Heart Rhythm; 2016 Jun; 13(6):1346-54. PubMed ID: 26921763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapper-1 is essential for Wnt5a induced cardiomyocyte hypertrophy by regulating the Wnt/PCP pathway.
    Hagenmueller M; Riffel JH; Bernhold E; Fan J; Katus HA; Hardt SE
    FEBS Lett; 2014 Jun; 588(14):2230-7. PubMed ID: 24879894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.